antagonisti glp 1 The GLP-1 Agonists and Obesity: How Diabetes Drugs are Changing Non-Diabetic Lives — tl;dr pharmacy PDB-101: Molecule of the Month:

Irfan Khan, MD, at Boca Medical Care.

Childhood obesity rates have skyrocketed over 300% since the 1970s, now affecting 21% of children

But here is a question that does not get asked enough: what happens to your Continue reading Can GLP-1 Medications Affect Athletic Performance and Recovery?

Patients who achieved weight loss with GLP-1 Receptor Agonists (RAs) can sustain their results with generic anti-obesity medications, including metformin, a study presented at the 61st Annual...

This review synthesizes current evidence on glucagon-like peptide-1 receptor agonists (GLP-1 RAs), a well-studied AOMs, focusing on their effects on sarcopenia through mechanistic insights and clinical considerations in older adults

Task force members report early experience across three distinct cases of locally advanced CRC in patients with severe obesity, demonstrating successful preoperative visceral fat reduction through multidisciplinary coordination incorporating metabolic bariatric surgery or pharmacologic therapy during neoadjuvant windows, followed by definitive oncologic resection